Clinical trial NCT02729220: Respiratory and Cardiovascular Effects in COPD
Official title: Respiratory and Cardiovascular Effects in COPD - Report From a Bronchoscopy Investigation Based on the Obstructive Lung Disease In the Northern Sweden (OLIN) Studies
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Pulmonary Disease, Chronic Obstructive
Keywords: Aging
Oxidative stress
Proteases
Bronchoscopy
Lead sponsor: University Hospital, Umeå
Sponsor class: OTHER
First posted: 2016-04-06
Enrollment: 52
Sex: ALL
Minimum age (years): 45
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: BASIC_SCIENCE

Brief summary: The purpose of this study is to find out if subjects with chronic obstructive pulmonary disease have signs of accelerated ageing in their airways.

Detailed description: The age-related impairment of innate immunity and antioxidant defenses likely impacts on development and disease progression of chronic obstructive pulmonary disease, COPD. It has been suggested that aging-related declines in function are accelerated in COPD due to recurrent cycles of inflammation, tissue injury and repair, associated with long-term exposure to cigarette smoke or other airway irritants. Here, the investigators aim to follow up on previous observations of impaired antioxidant responses in the lung of COPD patients, to establish the extent to which this reflects an accelerated aging phenotype, to characterize the molecular mechanisms resulting in this functional deficiency. The proposed studies will employ well-characterized patients with COPD of varying severity and smoking habits, as well as carefully age and smoking history-matched controls. Accelerated aging within the COPD lung will be assessed in endobronchial mucosal biopsies and airway macrophages by assessment of established senescence markers using immunohistochemical, biochemical and PCR-based methods. These markers of tissue age will then be related to the functional activation of transcription factors, known to be induced by oxidative stress and related to cytoprotection such as Nrf2 and AP1. The investigators will also examine whether COPD is associated with an enhanced secretion of inflammatory mediators from senescent cells, consistent with the accelerated aging paradigm and establish how this influences cell function. Deficiencies in metal handling, antioxidant defenses and diminished airway innate immune defenses at the air-lung interface will be assessed. The aim is to identify biomarkers for the risk of rapid lung function deterioration in COPD patients.

Eligibility criteria: Inclusion Criteria:

* Clinical diagnosis of COPD, GOLD stage 2-3.
* Smoking history of at least 10 packyears.

Exclusion Criteria:

* Severe ischemic heart disease.
* Other severe disease.
* Respiratory infection within four weeks.

Primary outcomes:
measure: Cellular senescence marker - Ki67
timeFrame: Baseline
measure: Matrix metalloproteinase 12 (MMP12) and the inhibitor TIMP1
timeFrame: Baseline
measure: Levels of oxidized proteins, 4 HNE
timeFrame: Baseline
measure: Antioxidant-related transcription factor Nrf2
timeFrame: Baseline
Secondary outcomes:
measure: Metals in airway lavages
timeFrame: Baseline
measure: Lymphocyte subsets in bronchoalveolar lavage
timeFrame: Baseline
measure: Arterial stiffness
timeFrame: Baseline
Other outcomes:
Locations:
city: Umeå
country: Sweden
facility: Department of Public Health and Clinical Medicine, Division of medicine, Pulmonary medicine
state: Sverige
Study officials:
References:
citation: Eriksson Strom J, Pourazar J, Linder R, Blomberg A, Lindberg A, Bucht A, Behndig AF. Airway regulatory T cells are decreased in COPD with a rapid decline in lung function. Respir Res. 2020 Dec 14;21(1):330. doi: 10.1186/s12931-020-01593-9.
citation: Eriksson Strom J, Pourazar J, Linder R, Blomberg A, Lindberg A, Bucht A, Behndig AF. Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking. Respir Res. 2018 Dec 7;19(1):244. doi: 10.1186/s12931-018-0940-7.